Cue Biopharma (CUE) Asset Utilization Ratio (2018 - 2025)
Historic Asset Utilization Ratio for Cue Biopharma (CUE) over the last 8 years, with Q3 2025 value amounting to 0.2.
- Cue Biopharma's Asset Utilization Ratio fell 1028.97% to 0.2 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.2, marking a year-over-year decrease of 1028.97%. This contributed to the annual value of 0.2 for FY2024, which is 17582.05% up from last year.
- Per Cue Biopharma's latest filing, its Asset Utilization Ratio stood at 0.2 for Q3 2025, which was down 1028.97% from 0.26 recorded in Q2 2025.
- Cue Biopharma's 5-year Asset Utilization Ratio high stood at 0.29 for Q1 2025, and its period low was 0.0 during Q1 2023.
- For the 5-year period, Cue Biopharma's Asset Utilization Ratio averaged around 0.13, with its median value being 0.12 (2024).
- As far as peak fluctuations go, Cue Biopharma's Asset Utilization Ratio plummeted by 9697.78% in 2023, and later surged by 233389.06% in 2024.
- Cue Biopharma's Asset Utilization Ratio (Quarter) stood at 0.18 in 2021, then tumbled by 91.93% to 0.01 in 2022, then soared by 466.62% to 0.08 in 2023, then skyrocketed by 186.51% to 0.24 in 2024, then fell by 18.64% to 0.2 in 2025.
- Its last three reported values are 0.2 in Q3 2025, 0.26 for Q2 2025, and 0.29 during Q1 2025.